This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HemaQuest Pharmaceuticals, Inc.
Drug Names(s): HQK-1004
Description: HQK-1004, a short chain fatty acid (SCFA) compound, acts by inducing the expression of a gene for a viral enzyme, thymidine kinase (TK) and is designed to treat hematologic malignancies associated with viruses.
Additional information available to subscribers only: